|
Genomic Health Announces Multiple Studies Highlighting Important Role Of Oncotype DX®
Genomic Health, Inc. (Nasdaq: GHDX) announced results from seven new studies focusing on its multigene Oncotype DX® breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide...
More... |
| All times are GMT -7. The time now is 11:05 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021